MARK BLOCH: Open Payments
NPI 1932388485 · MARTINEZ, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 15 payments from 6 companies in 2025. Trend: 2023 $469 · 2024 $264 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $205 |
| E.R. Squibb & Sons, L.L.C. | 2 | $129 |
| Gilead Sciences, Inc. | 1 | $100 |
| Neurocrine BioSciences, Inc. | 2 | $61 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| ABBVIE INC. | 1 | $29 |
Products named: CAPLYTA, COBENFY, INGREZZA, Auvelity, VRAYLAR.
Industry payments across CA — which companies pay providers there.
